The following abstracts and case studies were accepted for the CAP21 Virtual Abstract Program. Shown before each poster session are the subject areas for that session.(Poster No. 1)Haiyan Lu, MD, PhD1 (yanhailv@gmail.com); Breanna Perlmutter, MD2; Robert Naples, MD2; Toms Augustin, MD2; Daniela Allende, MD.1 Departments of 1Pathology and 2General Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.Context: Gallbladder adenocarcinoma has a poor overall survival (<5% at 5 years). We aim to design a risk-stratification model with novel and traditional features.Design: We retrospectively identified 57 gallbladder adenocarcinoma resection specimens from January 2009 through December 2017 at Cleveland Clinic Foundation. Clinical data were gathered and histologic features were obtained. Involvement by adenocarcinoma was defined as localized when a single anatomic region; remaining cases were considered diffuse. Kaplan-Meier analysis was used to estimate overall survival (OS) by using XLSTAT. Patients were risk stratified by using 2 prediction models, and receiver operating characteristic curve and area under the curve (AUC) were used to compare the models. P < .05 was considered statistically significant.Results: Of the 57 cases, 25 patients (43.9%) had localized disease at resection, whereas the rest had diffuse involvement of the gallbladder. The median follow-up was 29.7 months (range, 3.5–122 months). Twenty-six patients (45.6%) were dead from disease, with a median survival of 22.9 months (range, 3.8–61.5 months). Significant predictors of worse OS included diffuse involvement (P < .001), advanced stage (P = .02), and moderate to poor differentiation (P = .02). Lymphovascular invasion (LVI) showed a trend toward significance (P = .08). The risk-stratification model 1 (localized/diffuse extend of tumor, T stage, and tumor grade) provided better prediction for outcome (AUC = 0.721, P = .001) than model 2 (model 1 plus LVI) (AUC = 0.685, P = .009) (Table).Conclusions: Diffuse involvement, advanced stage, and moderate to poor differentiation are independent prognostic factors of worse outcome in gallbladder adenocarcinoma. Our risk-stratification model (disease extent, T stage, and tumor grade) provides substantial prediction on outcome.(Poster No. 2)Haiyan Lu, MD, PhD (yanhailv@gmail.com); Daniela Allende, MD; Xuefeng Zhang, MD, PhD. Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio.Context: Diabetes mellitus (DM) is a risk factor for pancreatic cancer, but its impact on postoperative outcomes remains controversial. It is unknown if prediagnostic diabetic status affects patient survival in tumors with any specific pathologic features.Design: We retrospectively identified 507 patients with pancreatic ductal adenocarcinoma (PDAC) between January 2008 and December 2018 at Cleveland Clinic Foundation. Clinical data and pathologic features were compared between patients with and without DM prior to the diagnosis. Statistical analysis was performed using IBM SPSS Statistics 19. Overall survival was compared in DM and non-DM groups using Kaplan-Meier analysis in XLSTAT. P < .05 was statistically significant.Results: In the cohort, 187 patients were diagnosed with DM prediagnostically and 320 patients stayed nondiabetic status prior to the diagnosis. Patients with DM tended to demonstrate worse overall survival (P = .06). In male patients, DM tended to negatively affect patients' overall survival (P = .06). Among the pathologic features, DM status was significantly related to a worse survival in patients with poorly differentiated carcinoma (P = .03), lymphovascular invasion (P = .02), or lymph node metastasis (P = .045). In patients with pT1 tumors defined by AJCC 7th or AJCC 8th edition, DM was significantly associated with a worse survival (AJCC 7th, P < .001; AJCC 8th, P = .04). In patients with AJCC 8th T2 tumor, there was a tendency that DM negatively affected patients' survival rate (P = .06) (Table).Conclusions: Prediagnostic DM status is associated with worse survival in PDAC patients with poorly differentiated carcinoma, lymphovascular invasion, or lymph node metastasis. DM tends to negatively affect survival rate in male patients and in patients with pT1 and pT2 tumors (AJCC 8th).(Poster No. 3)Subramanya Sakaleshpura Mallikarjunappa, MD (drsubramanyasm@gmail.com); Lin Cheng, MD, PhD; Shriram Jakate, MD. Department of Pathology, Rush University Medical Center, Chicago, Illinois.Context: Traditional serrated adenomas (TSAs) are the rarest of all the serrated polyps with distinctive endoscopic (“pine cone–like”) and histologic features. However, TSAs are underdiagnosed and the assessment of dysplasia in TSA is disputed. We retrospectively evaluated 62 TSAs to assess their clinicopathologic characteristics and associations.Design: A review of our database from 2014 through 2020 found 62 patients (32 men, 30 women, ages 34–84 years) diagnosed with TSA. Their clinical presentation, endoscopic/morphologic findings, sizes, multiplicity, distribution, associated other polyps, surveillance frequency, degree of dysplasia, and potential progression to invasive carcinoma were reviewed.Results: Most cases (59 of 62) were incidentally detected on screening colonoscopies. Polyps were 3–40 mm (mean, 12 mm). TSAs >10 mm were cold or hot snared and showed characteristic endoscopic pine cone appearance. Fifteen patients (24%) had solitary TSA and the rest showed other conventional adenomas and/or SSAs (76%). The majority (85%) of TSAs were in the distal colon: sigmoid (21), rectosigmoid (4), and rectum (28). All TSAs showed typical histologic features including ectopic crypt formation, slitlike serrations, elongated penicillate nuclei, and eosinophilic cytoplasm. Only 1 of 62 cases (1.6%) showed high-grade dysplasia.Conclusions: TSAs are incidentally detected on screening colonoscopy and are often associated with other conventional polyps than solitary TSA. Most TSAs are located in the sigmoid colon and rectum. High-grade dysplasia appears to be quite rare, even in large TSAs. Multicenter long-term studies are needed to evaluate the true risk of colorectal carcinoma in these unique polyps.(Poster No. 4)Miao Cui, MD, MS1 (Miao.Cui@mountsinai.org); Isaak Heon, DO2; Binny Khandakar, MD3; Daniel Chung, MD4; Jihong Sun, MD.2 1Department of Pathology, St Luke's-Roosevelt Hospital Center, Icahn School of Medicine at Mount Sinai, New York, New York; 2Department of Pathology, Mount Sinai West, New York, New York; 3Department of Pathology, Mount Sinai St. Luke's Roosevelt Hospital, New York, New York; 4Department of Pathology, Mount Sinai West, Icahn School of Medicine, New York, New York.Context: Pyloric gland adenoma (PGA) is a rare neoplasm of the gastric mucosa, involved in the gallbladder (GB), main pancreatic duct, and duodenum. Intracholecystic lesions of >1 cm are identified as intracholecystic papillary-tubular neoplasms (ICPNs), and lesions <1 cm are referred to pyloric gland hyperplasia/metaplasia. Our study aims to compare groups of PGA/metaplasia (<1 cm) in the GB and the luminal counterpart.Design: A retrospective study included cases of PGA or metaplasia at Mount Sinai West, New York, from January 1, 2000, to June 30, 2020. PGA from GB, >1 cm, or ICPN were excluded. Clinicopathologic parameters were analyzed, including age, gender, location of lesion, dysplasia, and the number of lesions (1/>1).Results: Forty-one cases (Table) were included. Among them, 14 cases were from both GB and duodenum, and 13 were from the stomach only. The mean age of presentation was 73 years. The mean age of GB, stomach, and duodenum groups was 59, 85, and 70 years, respectively. Chronic cholecystitis was present in 85% of cases. All cases involving the GB were >0.3 cm, with 6 cases >0.5 cm and another 4 cases 0.3–0.5 cm.Conclusions: According to our study, the terminology of “PGA” in the GB could aptly describe the lesions that are purely composed of pyloric glands in the GB, which may represent a true benign tumor rather than an inflammatory metaplastic process. “Adenoma” could be applied for mixed lesions, with overlapping morphology composed of an admixture of pancreaticobiliary and pyloric type, based on size or molecular signature.(Poster No. 5)Catherine E. Turner, MS (cet288@health.missouri.edu); Deepthi Rao, MD; Feng Yin, MD. Department of Pathology and Anatomic Sciences, University of Missouri–Columbia.Amyloidosis defines a group of disorders characterized by extracellular misfolded protein deposition, such as AL, AA, ATTR, and Aβ2M proteins. Clinical manifestations depend on the biochemical composition and site of deposition. Common sites include kidney, heart, and liver, but gastrointestinal amyloidosis is rare. The overall incidence of primary amyloidosis is 9 new cases per million persons, and involvement of gastrointestinal tract is exceptionally rare, with only an incidence of less than 1 per million. A 62-year-old man with past medical history of diverticulitis and colon resection presented to his physician with blood per rectum, unintentional weight loss, nausea, and vomiting for 1 month. He underwent esophagogastroduodenoscopy and colonoscopy. Biopsies of stomach and colon showed waxy, pale eosinophilic extracellular aggregates on microscopy (Figure 1.5, A), suggestive of amyloidosis, confirmed by Congo red staining (Figure 1.5, B) with apple-green birefringence in polarized light (Figure 1.5, C). These amyloid fibrils had a nonbranching, antiparallel twisted, β-pleated sheet configuration. Additional organ involvement was not found with imaging. This patient had no previous medical history of chronic inflammation, hematologic malignancy, renal disease, or family history, and the absence of risk factors suggested primary amyloidosis. The patient's κ:λ ratio and serum electrophoresis were unremarkable, proving primary amyloidosis. To our knowledge, this was the first ever reported case of gastric amyloidosis at University Hospital (Columbia, Missouri). Recognizing amyloidosis in a differential diagnosis is important, as early recognition of this disorder could prevent further complications for the patient, shorten time to diagnosis, and explore management options in an efficient manner.(Poster No. 6)Alexander Reese, DO1 (ahreese@usf.edu); Nushani Jaryatne, MD1; Kun Jiang, MD, PhD.2 1Department of Pathology, University of South Florida, Tampa; 2Department of Pathology, Moffitt Cancer Center, Tampa, Florida.Context: Gastrointestinal graft-versus-host disease (GVHD) poses a significant clinical and pathologic challenge following allogeneic hematopoietic transplantation. GVHD diagnosis requires clinical, laboratory, and histopathologic confirmation. Endoscopy has been fundamental in ensuring accurate diagnoses in numerous entities; however, an established correlation between endoscopic findings and GVHD remains undetermined.Design: The endoscopic findings of 185 histopathologically confirmed GVHD and 11 viral enterocolitis cases were reviewed retrospectively.Results: Among the 185 GVHD cases, 146 were grade 1, 26 were grade 2, 8 were grade 3, and 5 were grade 4. In the grade 1 cases, endoscopy was “normal” in 111 (76%) and abnormal in 35 (24%). Among the grade 2 cases, 21 were endoscopically “normal” (81%) whereas 5 appeared focally abnormal (19%). In the grade 3 cases, 6 (75%) were still considered “normal” and 2 abnormal (25%). Lastly, in the grade 4 cases a “normal” endoscopy was documented for 3 (60%), whereas an abnormal endoscopy was confirmed in only 2 (40%). Overall, endoscopic examination was “normal” in 141 of 185 GVHD cases (76%) and abnormal in only 44 (24%). Notably, in all 11 viral enterocolitis cases (7 cytomegalovirus and 4 adenovirus cases in which GVHD was clinically suspected), endoscopy was “normal.”Conclusions: To summarize, neither a satisfactory endoscopic sensitivity nor specificity was observed in the 185 GVHD cases; therefore, no correlation can be established between endoscopic findings and histopathologic GVHD. Furthermore, endoscopic abnormities are not only restricted to GVHD, but are also seen with infection, drug, and chemical-related injuries. Astute histopathologic inspection and ancillary tests remain the gold standard for discerning GVHD from its various mimickers.(Poster No. 7)Eric Ollila, MD1 (eollila@uabmc.edu); Abrar Alghamdi, MD1; Sameer Al Diffalha, MD1; Samuel Borak, MD.2 1Department of Pathology, University of Alabama at Birmingham; 2Department of Pathology, University of Alabama at Birmingham, Montgomery.Langerhans cell histiocytosis (LCH) is a group of idiopathic disorders characterized by an abnormal proliferation of dendritic mononuclear cells that mostly involves the skin and bones. Involvement of the gastrointestinal tract by LCH is exceedingly rare, and few cases have been reported. Here, we present 2 cases of LCH with gastrointestinal involvement and BRAF testing. The first case involves a 51-year-old man who presented with intermittent abdominal pain. Five polyps were found on colonoscopy. Histopathologic examination revealed an infiltrate in the lamina propria consisting of small to intermediatesized cells with variably irregular and focally reniform nuclei, with occasional nuclear grooves and mild amount of cytoplasm (Figure 1.7, A and B). Occasional mitotic figures and scattered eosinophils were present. These cells were immunohistochemically reactive with CD1a (Figure 1.7, C), S-100 (Figure 1.7, D), and CD43. BRAF testing was positive for the V600E mutation. The second case involves a 76-year-old woman who presented with a history of anemia and multiple episodes of C difficile colitis that resulted in gastrointestinal distress and weight loss. Two polyps were found on colonoscopy. Histopathologic examination revealed active inflammation involving surface epithelium and underlying crypts surrounded by prominent histocytes. These cells were reactive with S-100 and CD1a. BRAF testing results were negative. Although involvement of the gastrointestinal tract by LCH is rare, it should be considered in the differential diagnosis when a histiocytic proliferation is present. To our knowledge, these are the first cases of lower gastrointestinal tract involvement in polyps by LCH with reported BRAF testing, which may prove helpful in diagnosis and treatment.(Poster No. 8)Jiani N. Chai, MD, PhD1 (jichai@montefiore.org); Linlin Yang, MD, PhD2; Shaomin Hu, MD, PhD3; Yanhua Wang, MD, PhD1; Qiang Liu, MD1; Xuejun Tian, MD, PhD.1 1Department of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, New York, New York; 2Department of Pathology, The MetroHealth System, Cleveland, Ohio; 3Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio.Context: EZH2 is a histone methyltransferase associated with a poorer prognosis in several cancers. The regulation of EZH2 in colorectal cancer is unknown. Here we investigated EZH2 expression in colorectal cancer and its association with MYC, p-MAPK, and p-STAT3, potential regulators of EZH2.Design: One hundred fourteen colorectal cancer cases were collected. Immunohistochemical staining for EZH2, MYC, p-MAPK, p-STAT3, and Ki-67 was performed. EZH2 overexpression was defined if ≥60% neoplastic cells exhibited moderate to strong staining. MYC was positive if ≥40% neoplastic cells displayed moderate to strong staining. Statistical analysis was performed using Fisher exact test and Pearson correlation coefficient by Graphpad Prism (San Diego, California).Results: Eighty-six of 108 cases (79.6%) overexpressed EZH2. EZH2-overexpressed cases were more abundant in the moderate, moderate to poor/poor groups as compared with the well-differentiated tumor (P < .05) (Figure 1.8, A). Furthermore, EZH2 expression correlated positively with Ki-67 (P < .05) (Figure 1.8, B). We then investigated EZH2 expression in association with MYC, p-MAPK, and p-STAT3. Sixty-three of 103 cases (61.2%) expressed MYC, whereas very few expressed p-MAPK (2 of 104) or p-STAT3 (1 of 106). Among EZH2-overexpressed cases, 59 of 82 (72%) coexpressed MYC. EZH2 expression correlated positively with MYC (P < .001) (Figure 1.8, C). MYC also showed a positive correlation with Ki-67 (P < .01) (Figure 1.8, D).Conclusions: EZH2 overexpression is associated with more aggressive behavior in colorectal cancer, as indicated by the correlation with Ki-67 and tumor grade. Furthermore, MYC-related signaling, not p-MAPK or p-STAT3, might be involved in EZH2 regulation and correlated with tumor progression. Therefore, EZH2 and MYC could serve as potential prognostic and therapeutic targets for colorectal cancer.(Poster No. 9)Maria F. Gonzalez, MD1 (maferg13@yahoo.com); Allison L. Kerper, MD.2 Departments of 1Pathology and 2Medicine, College of Medicine, University of Illinois at Chicago.Context: Although the national incidence of colorectal cancer (CRC) has decreased in recent years, it remains the fourth most common cancer in the United States. The objective of this study is to identify if there is a statistically significant difference in the pathologic and molecular findings of CRC by race and ethnicity at our institution.Design: Patients with CRC resected from 2016 to 2019 were divided into 4 groups: white/non-Hispanic or Latino (N-HL), black/N-HL, Asian/N-HL, and other/HL. Risk factors, tumor location, grade, stage, size, invasion, and mutations were compared.Results: A total of 138 patients were included. A higher percentage of the tumors were located in the rectum in Asians/N-HL and others/HLs. In blacks/N-HL and whites/N-HL, CRCs were located in the right and left colon, respectively. CRC was resected earlier in whites/N-HL (60.0) and blacks/N-HL (61.7). Rectal carcinomas were more symptomatic and presented earlier (50s–60s) than colonic carcinomas (60s–70s), especially in whites/N-HL. In contrast, blacks/N-HL and Asians/NH-L showed a later peak in age for rectal cancer (70–79) than colon cancer (50–59). Most cases were diagnosed at early stages in blacks/N-HL and other/HL. Twenty-two patients (15.9%) had young-onset CRC. Most of the CRCs were microsatellite stable. Microsatellite-instable-high CRC (14.5%) presented as advanced well/moderately differentiated rectal carcinomas in blacks/NHL (Table).Conclusions: Our study demonstrates that the pathologic parameters for the examination of CRC described by the College of American Pathologists do not display statistically significant differences among races/ethnicities. The high percentage of CRC in the rectum in white/NHL, Asian/N-HL, and other/HL has important implications for CRC screening via rectosigmoidoscopy.(Poster No. 10)Xiaobang Hu, MD, PhD1 (xiaobang.hu@phhs.org); Elena Lucas, MD1; Amarpreet Bhalla, MD2; Maria Westerhoff, MD3; ILKe Nalbantoglu, MD4; Nicole Panarelli, MD2; Jerome Cheng, MD3; Suntrea Hammer, MD1; Purva Gopal, MD, MS.1 1Department of Pathology, UT Southwestern Medical Center, Dallas, Texas; 2Department of Pathology, Albert Einstein/Montefiore Medical Center, Bronx, New York; 3Department of Pathology, University of Michigan, Ann Arbor; 4Department of Pathology, Yale School of Medicine, New Haven, Connecticut.Context: A preliminary study by our group suggested for patients with biopsy diagnosis of active or inactive chronic gastritis (CG) with a pattern that is highly suggestive of Helicobacter pylori (HP) infection but negative HP immunohistochemistry (IHC), a comment raising the possibility of HP infection can change the clinical management.Design: We conducted a retrospective comparison study of patients from an academic center in the South (group 1) to 3 centers in the Midwest/Northeast (group 2), all with a diagnosis of CG with negative HP IHC.Results: A total of 19.2% of group 1 patients and 56.8% of group 2 patients were on a nonsteroidal anti-inflammatory drug (NSAID) prior to biopsy (P < .01), whereas 36.4% of group 1 patients and 63.9% of group 2 patients were on a proton pump inhibitor (PPI) prior to biopsy (P < .01). Group 1 patients more frequently had HP history (47.4% versus 21.6%, P < .01). After the diagnosis, 48.7% of group 1 and 11.1% of group 2 received treatment (P < .001). Of those treated, 14.1% and 6.7% received HP treatment, respectively (triple or quadruple therapy; P > .05). In cases with a comment in the pathology report raising the possibility of HP, patients from the South received HP treatment more often as compared with cases without a comment (25.6% versus 2.6%, P < .01). This trend is similar for the Midwest/Northeast institutions (14.3% versus 0%, P = .06) (Table).Conclusions: Our data suggest a regional difference in patient management after diagnosis of CG with negative HP IHC in that patients from the South were more frequently treated. A comment in the pathology report describing HP-pattern gastritis despite negative HP IHC increased HP treatment, especially in the South.(Poster No. 11)Khairya Fatouh, MD (khairya.fatouh@ascension.org); Sulmaz Zahedi, MHSs; Basim Al-Khafaji, MD. Department of Pathology, Ascension St. John and Medical Center, Detroit, Michigan.Colonic mixed neuroendocrine-nonneuroendocrine neoplasms are a rare entity. The term has evolved with the World Health Organization adopting the current nomenclature in 2017. We present a case of a 59-year-old woman who presented with acute abdomen and a perforated viscus. Explorative laparotomy revealed 2 right colon masses with tumor seeding of multiple peritoneal sites. Histologic evaluation of the tumor identified 2 components, one forming 40%, consisting of sheets of poorly differentiated small hyperchromatic cells with conspicuous nuclei, admixed with a conventional colonic adenocarcinoma; both involved the full thickness of bowel wall and invaded into peri-colonic fibroadipose tissue. Strong positive staining of immunohistochemical markers synaptophysin, chromogranin, CD56, cytokeratin AE1/AE3, cytokeratin 20, and with focal positivity for CDX2 and negativity for TTF-1, was identified in the neuroendocrine component, whereas the conventional adenocarcinoma was positive only for Ber-EP4, CDX2, cytokeratin AE1/AE3, and cytokeratin 20. Additionally, Ki-67 showed 100% positive staining within the entire tumor. Subsequently, the patient developed seizures associated with brain metastasis and expired 2 months later. Mixed neuroendocrine-nonneuroendocrine neoplasms with a poorly differentiated neuroendocrine component are associated with an extremely poor prognosis with an average of 4.5-month survival in patients with stage 4. Mixed neuroendocrine-nonneuroendocrine neoplasm is a rare entity that requires diligent histologic evaluation to identify the neuroendocrine component histologically and immunohistochemically. Although the current criteria suggest a minimal 30% portion of each component, further clinical and histopathologic studies are required to validate these measures and establish appropriate therapy regiments.(Poster No. 12)Irene Y. Chen, MD (irene_chen@urmc.rochester.edu); Xiaoqing Liu, MD, PhD; Sierra Kovar, MS, CT(ASCP); Xiaoyan Liao, MD, PhD. Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.Context: Appendiceal goblet cell adenocarcinoma (GCA) is a unique tumor composed of gobletlike cells. The 2019 World Health Organization criteria recommend a 3-tiered grading system based on proportion of low-grade and high-grade patterns. We aim to validate this grading schema with correlation to tumor stage, immunohistochemistry, and patient survival.Design: All cases of GCA staged pT3 and above were retrieved (2005–2020). P values <.05 were considered significant.Results: Our cohort consisted of 13 males and 12 females with median age of 62.5 years. Pathologically, 13 were pT3 and 12 were pT4, with 9 cases (36%) demonstrating lymph node and/or distant metastasis. Clinically, 15 (60%) were stage II, 4 (16%) stage III, and 6 (24%) stage IV. Using the 3-tier grading system, 10 (40%) were G1, 7 (28%) G2, and 8 (32%) G3. Immunohistochemically, all cases were mismatch repair proficient. Loss of nuclear SMAD4 expression and abnormal p53 expression occurred at equally low frequencies (n = 3, 12% each). Seven cases (28%) showed nuclear β-catenin positivity. The Ki-67 index (range, 1%–80%) were tiered into low (<5%, n = 8), intermediate (5%–20%, n = 10), and high (>20%, n = 7). Statistically, the histologic grade correlated with clinical stage (P < .001), but not with sex, age, Ki-67 index, or nuclear SMAD4/p53/β-catenin abnormalities. The histologic grade, T stage, lymph, node and distant metastasis were associated with reduced survival (P < .05).Conclusions: The current grading system for GCA correlated well with clinical stage and disease outcomes. A small percentage of GCA demonstrated nuclear SMAD4, p53, or β-catenin abnormalities, which did not correlate significantly with histologic grade, tumor stage, or patient survival.(Poster No. 13)Abdullah Osme, MD (abdullah.osme@uhhospitals.org); Wei Xin, MD, PhD. Department of Pathology, University Hospitals Cleveland Medical Center/Case Western University, Cleveland, Ohio.Primary pancreatic signet ring cell carcinoma (PPSRCC) is a rare histologic variant of pancreatic ductal adenocarcinoma. We report a case of PPSRCC in a 52-year-old woman with a confirmed personal history of hereditary nonpolyposis colorectal cancer with MSH2 germline mutation. The patient had abdominal pain, and computed tomography showed a pancreatic body mass. Ultrasound-guided fine-needle aspiration (FNA) biopsy of the pancreas was nonconclusive. Eventually, the patient underwent distal pancreatosplenectomy. Gross examination revealed a tan-white, poorly demarcated and unencapsulated mass located at the body, measuring 1.9 × 1.4 × 1.0 cm, and obstructing the pancreatic duct. Hematoxylin-eosin sections showed a polypoid mass occupying the pancreatic duct consisting of a predominant signet ring cell carcinoma. There was also some well-differentiated ductal adenocarcinoma component (20%). Because of the tumor obstruction of the pancreatic duct, distal pancreas showed extensive chronic pancreatitis. Immunostains showed the loss of MSH2 and MSH6 in the signet ring cell carcinoma with proper positive background staining. The patient did not have signet ring cell carcinoma in other parts of the gastrointestinal (GI) tract. Therefore, this is a primary signet ring cell carcinoma in a Lynch syndrome patient. The most common signet ring carcinoma site is the stomach and occasionally can be found in other parts of the GI tract, but pancreas is a rare place for the primary signet ring cell carcinoma. Lynch syndrome tends to be associated with poorly differentiated carcinoma, including signet ring cell carcinoma in colon, but has not been reported in pancreas. It imposes a diagnostic challenge for FNA cytology and frozen section if not aware of this rare variant.(Poster No. 14)Yan Wang, MD (ywang3@metrohealth.org); Ali Shahabi, MD; Agnes Loeffler, MD, PhD. Department of Pathology, Metrohealth Medical Center, Cleveland, Ohio.Context: During the past 3 decades, multiple diagnostic terms have been applied to the entity we now call low-grade or high-grade appendiceal mucinous neoplasm (LAMN/HAMN). We undertook this study to understand the rate of adoption of World Health Organization guidelines regarding the reporting of this entity in a community practice setting.Design: We conducted a retrospective study of all the neoplastic appendiceal cases in a county hospital in Cleveland from 1999 to 2019. The cases were reviewed by 3 pathologists, including 1 gastrointestinal pathologist. In the cases of appendiceal mucinous neoplasm, we compared the terminology used at the time of diagnosis with contemporary nomenclature and grading.Results: A total of 32 patients with appendiceal mucinous neoplasia were identified (LAMN [n = 30] and HAMN [n = 2]), 13 of these since 2010. Twenty-six of the cases (81.2%) would now receive another name, and of these, there were diagnostic discrepancies in 5 cases (19.2%) (Table). Anachronistic terminology continued to be used at least until 2019 (7 of 13 cases; 53.8%). None of these changes would have had an impact on the further management or clinical follow-up of the patients.Conclusions: Despite frequent updates and consensus guidelines for pathologic assessment of appendiceal mucinous lesions, in the past 2 decades there has been considerable confusion around how these entities should be named and graded. Our findings suggest that pathologists should consider a second opinion in these unusual cases, especially since a history of terminologic abundance has created inconsistency in the diagnostic approach to the entity.(Poster No. 15)Bitania Wondimu, MD (bmw35@uw.edu); Benjamin Bradley, MD, PhD; Joshua Lieberman, MD, PhD; Seth Cohen, MD, MSc; Lynda Bui, MLS; Deepti Reddi, MD. Department of Pathology, University of Washington Medical Center, Seattle.Isolation of Cokeromyces recurvatus, a dimorphic fungus in Zygomycete family, is equivocal because it is uncertain whether the organism is a pathogen or a tissue contaminant/colonizer. We report a case of C recurvatus present in a circumferential duodenal lesion. The patient is a 64-year-old man with medical history notable only for heavy consumption of edible marijuana, admitted with a 3-week history of left upper quadrant abdominal pain. Computerized tomography scan identified duodenitis with significant gastric outlet obstruction, confirmed by a partially obstructing nonbleeding duodenal ulcer on upper endoscopy (Figure 1.15, A). The histology showed variably sized spherical structures with bubbly internal contents and no nuclei, reproductive tracts, or alimentary tracts. Small, clustered spherules representing putative endospores were observed within the larger structures and in the exud